Compare PBLS & AEHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PBLS | AEHR |
|---|---|---|
| Founded | N/A | 1977 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electrical Products |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 3.0B |
| IPO Year | 2026 | 1997 |
| Metric | PBLS | AEHR |
|---|---|---|
| Price | $31.50 | $72.19 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $29.50 |
| AVG Volume (30 Days) | 463.8K | ★ 2.9M |
| Earning Date | N/A | 04-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $58,968,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $71.04 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $25.56 | $15.94 |
| 52 Week High | $33.65 | $126.62 |
| Indicator | PBLS | AEHR |
|---|---|---|
| Relative Strength Index (RSI) | 57.58 | 45.18 |
| Support Level | $26.83 | $22.39 |
| Resistance Level | $33.65 | $107.14 |
| Average True Range (ATR) | 2.51 | 9.29 |
| MACD | 0.15 | 0.82 |
| Stochastic Oscillator | 68.05 | 29.29 |
Parabilis Medicines Inc s a clinical-stage biopharmaceutical company. It is focused on the development of medicines targeting protein interactions associated with human diseases. It uses a proprietary platform to develop stabilized helical peptide therapeutics, referred to as Helicons, designed to bind and modulate specific proteins. Its flagship product candidate, zolucatetide, targets the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors within the Wnt/β-catenin signaling pathway, which is associated with cell proliferation and differentiation in multiple cancer types.
Aehr Test Systems is engaged in test systems for burning-in and testing logic, optical, and memory integrated circuits. Increased quality and reliability needs of the Automotive and Mobility integrated circuit markets. The Company operates in one business segment, the designing, manufacturing, marketing and selling of advanced test and burn-in products to the semiconductor manufacturing industry in several geographic areas. The company provides production solutions across the product manufacturing flow to improve yield and reliability and has developed and introduced several inventive products, including the ABTSTM and FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX-XP WaferPak Contactor, FOX DiePak Carrier and FOX DiePak Loader.